Asclepii

Asclepii is creating the next generation of regenerative therapy through Artemis™, a revolutionary therapeutic platform that turns a $30,000 autologous therapy into $300. The technology aims to tackle pressing clinical needs in the chronic wound space, helping to improve the treatment of medical complications such as diabetic foot ulcers, and eventually venturing into organ manufacturing.